Literature DB >> 20943767

Early glomerular alterations in genetically determined low nephron number.

Kerstin Benz1, Valentina Campean, Nada Cordasic, Britta Karpe, Winfried Neuhuber, Gerhard Mall, Andrea Hartner, Karl F Hilgers, Kerstin Amann.   

Abstract

An association between low nephron number and subsequent development of hypertension in later life has been demonstrated. The underlying pathomechanisms are unknown, but glomerular and postglomerular changes have been discussed. We investigated whether such changes are already present in prehypertensive "glial cell line-derived neurotrophic growth factor" heterozygous mice (GDNF+/-) with lower nephron number. Twenty-six-week-old mice [22 GDNF+/-, 29 C57B6 wild-type control (wt)] were used for in vivo experiments with intra-arterial and tail cuff blood pressure measurements. After perfusion fixation, kidneys were investigated with morphological, morphometric, stereological, and immunohistochemical techniques and TaqMan PCR analysis. As expected at this age, blood pressure was comparable between GDNF+/- and wt. Nephron number per kidney was significantly lower in GDNF+/- than in wt (-32.8%, P < 0.005), and mean glomerular volume was significantly higher (+49.5%, P < 0.001). Renal damage scores, glomerular and tubular proliferation, analysis of intrarenal arteries and peritubular capillaries, expression of relevant tubular transporter proteins, as well as gene expression of profibrotic, proinflammatory, or prohypertensive markers were not significantly different between GDNF+/- and wt. Compensatory glomerular hypertrophy in GDNF+/- was accompanied by higher numbers of endothelial and mesangial cells as well as PCNA-positive glomerular cells, whereas podocyte density was significantly reduced. Further electron microscopic analysis showed marked thickening of glomerular basement membrane. In conclusion, lower nephron number is associated with marked early glomerular structural changes, in particular lower capillary supply, reduced podocyte density, and thickened glomerular basement membrane, that may predispose to glomerular sclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943767     DOI: 10.1152/ajprenal.00490.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

Review 1.  Signal transduction in podocytes--spotlight on receptor tyrosine kinases.

Authors:  Jochen Reiser; Sanja Sever; Christian Faul
Journal:  Nat Rev Nephrol       Date:  2014-01-07       Impact factor: 28.314

2.  The number of fetal nephron progenitor cells limits ureteric branching and adult nephron endowment.

Authors:  Cristina Cebrian; Naoya Asai; Vivette D'Agati; Frank Costantini
Journal:  Cell Rep       Date:  2014-03-20       Impact factor: 9.423

3.  Does a nephron deficit exacerbate the renal and cardiovascular effects of obesity?

Authors:  Seshini Gurusinghe; Russell D Brown; Xiaochu Cai; Chrishan S Samuel; Sharon D Ricardo; Merlin C Thomas; Michelle M Kett
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

Review 4.  Reprogramming: A Preventive Strategy in Hypertension Focusing on the Kidney.

Authors:  You-Lin Tain; Jaap A Joles
Journal:  Int J Mol Sci       Date:  2015-12-25       Impact factor: 5.923

5.  Molecular regulation of kidney development.

Authors:  Ok-Hee Chai; Chang-Ho Song; Sung-Kwang Park; Won Kim; Eui-Sic Cho
Journal:  Anat Cell Biol       Date:  2013-03-25

6.  Renal Transcriptome Analysis of Programmed Hypertension Induced by Maternal Nutritional Insults.

Authors:  You-Lin Tain; Chien-Ning Hsu; Julie Y H Chan; Li-Tung Huang
Journal:  Int J Mol Sci       Date:  2015-08-03       Impact factor: 5.923

7.  Missense Mutation of POU Domain Class 3 Transcription Factor 3 in Pou3f3L423P Mice Causes Reduced Nephron Number and Impaired Development of the Thick Ascending Limb of the Loop of Henle.

Authors:  Alexandra Rieger; Elisabeth Kemter; Sudhir Kumar; Bastian Popper; Bernhard Aigner; Eckhard Wolf; Rüdiger Wanke; Andreas Blutke
Journal:  PLoS One       Date:  2016-07-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.